Viewing Study NCT05058118


Ignite Creation Date: 2025-12-25 @ 4:59 AM
Ignite Modification Date: 2025-12-26 @ 3:59 AM
Study NCT ID: NCT05058118
Status: COMPLETED
Last Update Posted: 2021-09-27
First Post: 2021-09-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Evaluation of the Safety, Tolerability and Pharmacokinetics of Intravenous FL058 Administered in Healthy Subjects(SAD)
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: FL058-I-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators